Literature DB >> 4622128

Acid-soluble nucleotides in an asporogenous mutant of Bacillus subtilis.

C T Chow, I Takahashi.   

Abstract

An asporogenous mutant of Bacillus subtilis Sp(-)H12-3, which is considered to have a block at stage 0, showed general growth characteristics similar to those of sporulating cultures. However, a sudden increase in the total amount of acid-soluble nucleotides observed at t(2) in sporulating bacteria was completely absent in this mutant. In sporulating cells, a marked increase in two nucleotides which were identified to be uridine diphosphate (UDP)-galactose and UDP-N-acetylglucosamine was noted, whereas UDP-glucose appeared to be accumulated in the mutant cells at t(2). No unusual nucleotides were found in the strains of B. subtilis examined. The possible role of these UDP derivatives in early stages of sporulation in B. subtilis is discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4622128      PMCID: PMC247341          DOI: 10.1128/jb.109.3.1175-1180.1972

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  Biochemical changes occurring during growth and sporulation of Bacillus cereus.

Authors:  H M NAKATA; H O HALVORSON
Journal:  J Bacteriol       Date:  1960-12       Impact factor: 3.490

2.  Synthesis of nucleic acids in Escherichia coli.

Authors:  L SIMINOVITCH; A F GRAHAM
Journal:  Can J Microbiol       Date:  1955-12       Impact factor: 2.419

3.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

4.  Uridine nucleotide compounds of liver.

Authors:  E E SMITH; G T MILLS
Journal:  Biochim Biophys Acta       Date:  1954-03

5.  Uridine diphosphate acetylglucosamine.

Authors:  E CABIB; L F LELOIR; C E CARDINI
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

6.  Nucleotide metabolism. II. Chromatographic separation of acid-soluble nucleotides.

Authors:  R B HURLBERT; H SCHMITZ; A F BRUMM; V R POTTER
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

7.  Genetic transcription in asporogenous mutants of Bacillus subtilis.

Authors:  H Yamagishi; I Takahashi
Journal:  Biochim Biophys Acta       Date:  1968-01-29

Review 8.  Bacterial sporulation as a modified procaryotic cell division.

Authors:  A D Hitchins; R A Slepecky
Journal:  Nature       Date:  1969-08-23       Impact factor: 49.962

9.  CHANGES IN THE NUCLEOTIDE POLL OF BACILLUS LICHENIFORMIS DURING SPORULATION.

Authors:  C LEITZMANN; R W BERNLOHR
Journal:  J Bacteriol       Date:  1965-06       Impact factor: 3.490

10.  TRANSDUCTION OF SPOROGENESIS IN BACILLUS SUBTILIS.

Authors:  I TAKAHASHI
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

View more
  5 in total

1.  Incorporation of 32Pi into nucleotides, polyphosphates, and other acid-soluble compounds by Myxococcus xanthus during myxospore formation.

Authors:  P Y Maeba; R Shipman
Journal:  J Bacteriol       Date:  1978-12       Impact factor: 3.490

2.  Inactivation of aspartic transcarbamylase in sporulating Bacillus subtilis: demonstration of a requirement for metabolic energy.

Authors:  L M Waindle; R L Switzer
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

3.  Accessibility of the (14C)benzylpenicillin binding proteins in membranes of sporulating bacilli.

Authors:  T E Hamilton; P J Lawrence
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

4.  Binding of radioactive benzylpenicillin to asporogenous mutants of Bacillus subtilis during postexponential growth.

Authors:  M Rogolsky; P J Lawrence; V T Hanh
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

5.  Penicillin: reversible inhibition of forespore septum development in Bacillus megaterium cells.

Authors:  P J Lawrence
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.